Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bristol Myers Squibb (BMYMP) Income from Continuing Operations (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Income from Continuing Operations for 17 consecutive years, with 1086000000.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations rose 1328.95% to 1086000000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 7056000000.0 through Dec 2025, up 178.99% year-over-year, with the annual reading at 7056000000.0 for FY2025, 178.99% up from the prior year.
  • Income from Continuing Operations for Q4 2025 was 1086000000.0 at Bristol Myers Squibb, down from 2195000000.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 2462000000.0 in Q1 2025, with the low at 11908000000.0 in Q1 2024.
  • Average Income from Continuing Operations over 5 years is 976100000.0, with a median of 1646000000.0 recorded in 2022.
  • The sharpest move saw Income from Continuing Operations soared 1426.25% in 2021, then tumbled 625.28% in 2024.
  • Over 5 years, Income from Continuing Operations stood at 2372000000.0 in 2021, then fell by 14.63% to 2025000000.0 in 2022, then fell by 12.99% to 1762000000.0 in 2023, then tumbled by 95.69% to 76000000.0 in 2024, then surged by 1328.95% to 1086000000.0 in 2025.
  • According to Business Quant data, Income from Continuing Operations over the past three periods came in at 1086000000.0, 2195000000.0, and 1313000000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.